Process impurities can have negative effects on process materials and final products

Antifoam agents, divalent metal cations, and EDTA impurities are often associated with the manufacturing and formulation process of biologics. Bureau Veritas has developed a number of analytical procedures required for in-process monitoring as well as bulk and final product release testing. We specialize in validation of analytical methods involving many complex matrices associated with bio-pharmaceutical product development.